Hologic and R2 sign definitive agreement
A deal announced July 31 between women's health equipment vendor Hologic and R2 Technology calls for the integration of the CAD pioneer's ImageChecker into Hologic's Lorad Selenia full-field digital mammography system. The agreement grants Hologic
A deal announced July 31 between women's health equipment vendor Hologic and R2 Technology calls for the integration of the CAD pioneer's ImageChecker into Hologic's Lorad Selenia full-field digital mammography system. The agreement grants Hologic worldwide distribution rights for R2's OmniCAD Digital and film-based mammography suite of products customized for use with Selenia. The five-year agreement, which has two one-year renewal options, also provides Hologic the right to sell R2's film-based CAD products in conjunction with its digital-ready conventional screen-film mammography products.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
